PVR and breast cancer: The study by Stamm et al. has demonstrated that the blocking of TIGIT or CD155 induces the lysis of BC cells via healthy donor peripheral blood mononuclear cells (HD-PBMCs) and cytokine-induced killer cells (CIKs) derived ex vivo from HD-PBMCs [92].